ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 321 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $1,144,000 | -19.3% | 19,887 | -10.6% | 0.02% | -10.7% |
| Q1 2015 | $1,417,000 | +15.4% | 22,257 | +11.9% | 0.03% | +21.7% |
| Q4 2014 | $1,228,000 | +12.0% | 19,887 | -29.6% | 0.02% | +21.1% |
| Q3 2014 | $1,096,000 | +12.6% | 28,237 | 0.0% | 0.02% | +18.8% |
| Q2 2014 | $973,000 | -20.2% | 28,237 | 0.0% | 0.02% | -20.0% |
| Q1 2014 | $1,220,000 | +8.4% | 28,237 | 0.0% | 0.02% | 0.0% |
| Q4 2013 | $1,125,000 | – | 28,237 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |